General Truisms

Malignant parotid neoplasms represent 1 to 3% of carcinomas of the head and neck. Recurrence of these malignancies is often synonymous with future therapeutic failure. Identifying the covari-ables suggestive of aggressive behavior and recurrence could alter initial therapeutic planning. Tumor stage, including extension, facial nerve involvement, and histologic grading are the most significant prognostic indicators.1 Integrating the aforementioned into a realistic therapeutic plan is still best accomplished by case individualization, with decision making reflecting significant physician experience. Some points as to data acquisition and interpretation follow. The realities of cost containment are reflected in the management strategies proposed but are not further specified.

0 0

Post a comment